Biomarkers for prostate cancer detection
- PMID: 20014890
- DOI: 10.1586/era.09.168
Biomarkers for prostate cancer detection
Abstract
Since its approval by the US FDA in 1986, prostate-specific antigen (PSA) has been employed to monitor men with a diagnosis of prostate cancer. In 1994, PSA was approved for use in prostate cancer screening and has been employed worldwide. However, due to the limited specificity of PSA for the disease, novel biomarkers are needed for detecting prostate cancer and for determining which cancers need to be treated. This review will discuss the development of new biomarkers for prostate cancer detection and disease prognostication, focusing on recent progress and particular topical issues related to the development and validation of these new markers.
Similar articles
-
New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.Anticancer Res. 2009 Aug;29(8):3289-98. Anticancer Res. 2009. PMID: 19661347 Review.
-
Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.Cancer. 2004 Sep 1;101(5):894-904. doi: 10.1002/cncr.20480. Cancer. 2004. PMID: 15329895 Review.
-
Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen.Curr Opin Urol. 2009 May;19(3):243-6. doi: 10.1097/MOU.0b013e32832a08b5. Curr Opin Urol. 2009. PMID: 19325493 Review.
-
Other biomarkers for detecting prostate cancer.BJU Int. 2010 Jan;105(2):166-9. doi: 10.1111/j.1464-410X.2009.09088.x. Epub 2009 Nov 20. BJU Int. 2010. PMID: 19930175 Review.
-
Biomarkers for prostate cancer detection.J Urol. 2007 Dec;178(6):2252-9. doi: 10.1016/j.juro.2007.08.055. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936845 Review.
Cited by
-
Inflammation: an important parameter in the search of prostate cancer biomarkers.Proteome Sci. 2014 Jun 9;12:32. doi: 10.1186/1477-5956-12-32. eCollection 2014. Proteome Sci. 2014. PMID: 24944525 Free PMC article.
-
The emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy.J Extracell Vesicles. 2015 Jun 30;4:23815. doi: 10.3402/jev.v4.23815. eCollection 2015. J Extracell Vesicles. 2015. PMID: 26134460 Free PMC article.
-
Clinical and oncological outcomes of robot-assisted radical prostatectomy with nerve sparing vs. non-nerve sparing for high-risk prostate cancer cases.Oncol Lett. 2019 Oct;18(4):3896-3902. doi: 10.3892/ol.2019.10692. Epub 2019 Jul 31. Oncol Lett. 2019. PMID: 31579411 Free PMC article.
-
Evaluation of prediction models for the staging of prostate cancer.BMC Med Inform Decis Mak. 2013 Nov 15;13:126. doi: 10.1186/1472-6947-13-126. BMC Med Inform Decis Mak. 2013. PMID: 24238348 Free PMC article.
-
Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer.Cancers (Basel). 2022 Nov 14;14(22):5595. doi: 10.3390/cancers14225595. Cancers (Basel). 2022. PMID: 36428686 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous